SELARL PHARMACIE DEMANOU : revenue, balance sheet and financial ratios

SELARL PHARMACIE DEMANOU is a French company founded 10 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in ARGENTEUIL (95100), this company of category PME shows in 2020 a revenue of 901 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE DEMANOU (SIREN 814154696)
Indicator 2023 2022 2020 2019 2018 2017 2016
Revenue N/C N/C 901 496 € 788 941 € 790 568 € 787 492 € 950 752 €
Net income 87 576 € 123 805 € 83 073 € 45 908 € 48 773 € 55 597 € 28 648 €
EBITDA N/C N/C 107 385 € 56 764 € 64 606 € 49 808 € 19 133 €
Net margin N/C N/C 9.2% 5.8% 6.2% 7.1% 3.0%

Revenue and income statement

In 2023, SELARL PHARMACIE DEMANOU generates positive net income of 88 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 29 k€ -> 88 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

87 576 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 32%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 54%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

31.841%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

54.388%

Solvency indicators evolution
SELARL PHARMACIE DEMANOU

Sector positioning

Debt ratio
31.84 2023
2020
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good

In 2023, the debt ratio of SELARL PHARMACIE DEMANOU (31.84) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
54.39% 2023
2020
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good

In 2023, the financial autonomy of SELARL PHARMACIE DEMANOU (54.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
1.69 years 2020
2020
Q1: 1.45 years
Med: 4.71 years
Q3: 9.29 years
Good

In 2020, the repayment capacity of SELARL PHARMACIE DEMANOU (1.69) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 190.41. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

190.41

Liquidity indicators evolution
SELARL PHARMACIE DEMANOU

Sector positioning

Liquidity ratio
190.41 2023
2020
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Good -25 pts over 3 years

In 2023, the liquidity ratio of SELARL PHARMACIE DEMANOU (190.41) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
3.17x 2020
2020
Q1: 0.68x
Med: 3.88x
Q3: 8.36x
Average

In 2020, the interest coverage of SELARL PHARMACIE DEMANOU (3.2x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL PHARMACIE DEMANOU

Positioning of SELARL PHARMACIE DEMANOU in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2023, the value of SELARL PHARMACIE DEMANOU is estimated at 1 033 350 € (range 628 430€ - 1 452 659€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
220 transactions
628k€ 1033k€ 1452k€
1 033 350 € Range: 628 430€ - 1 452 659€
NAF 5 année 2023

Valuation method used

Net Income Multiple
87 576 € × 11.8x = 1 033 351 €
Range: 628 430€ - 1 452 660€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DEMANOU with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE DEMANOU

What is the revenue of SELARL PHARMACIE DEMANOU ?

The revenue of SELARL PHARMACIE DEMANOU in 2020 is 901 k€.

Is SELARL PHARMACIE DEMANOU profitable?

Yes, SELARL PHARMACIE DEMANOU generated a net profit of 88 k€ in 2023.

Where is the headquarters of SELARL PHARMACIE DEMANOU ?

The headquarters of SELARL PHARMACIE DEMANOU is located in ARGENTEUIL (95100), in the department Val-d'Oise.

Where to find the tax return of SELARL PHARMACIE DEMANOU ?

The tax return of SELARL PHARMACIE DEMANOU is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DEMANOU operate?

SELARL PHARMACIE DEMANOU operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.